Incidence of Pneumocystosis Among Patients Exposed to Immunosuppression

•This population analysis add to the limited data that guides dermatologists on need to administer prophylaxis against pneumocystosis with trimethoprim/sulfamethoxazole. Benefit of prophylaxis with trimethoprim/sulfamethoxazole appears to outweigh risk of severe drug reaction for patients receiving combination corticosteroid and immunosuppressant therapy.

http://bit.ly/2VDMbt6